MOTS-c
Mitochondrial-Nuclear Retrograde Signaling
What is MOTS-c?
MOTS-c (mitochondrial open reading frame of the twelve-S rRNA type-c) is a 16-amino-acid mitochondrial-derived peptide (MDP) encoded within the mitochondrial genome rather than the nuclear genome. It was first characterized in the mid-2010s as part of a small family of peptides that mitochondria appear to use as signaling molecules. Research suggests MOTS-c functions as a retrograde signal — a message sent from the mitochondria back to the nucleus — that helps coordinate cellular metabolism, particularly under conditions of metabolic stress. In preclinical models it has been reported to translocate to the nucleus, where it is proposed to influence the expression of stress- and metabolism-related genes.
Mechanistically, much of the published work centers on the AMPK pathway, a central energy-sensing system in the cell. Studies in cultured cells and rodents suggest MOTS-c can activate AMPK signaling, which is associated with increased glucose uptake in skeletal muscle and improved insulin sensitivity in these experimental settings. Because of this, MOTS-c has drawn interest in metabolic and exercise-physiology research, where investigators have examined its levels in relation to physical activity and aging. Some rodent studies have explored whether MOTS-c administration affects metabolic flexibility, body composition, or exercise capacity, and circulating MOTS-c has been reported to decline with age in certain measurements.
It is important to frame these findings carefully. The great majority of the MOTS-c literature is preclinical — cell culture and animal work — and the peptide is best understood as an active area of basic research rather than an established intervention. Effects observed in mice or in vitro do not necessarily translate to humans, and the field is still working out MOTS-c's precise mechanisms, kinetics, and physiological roles. MOTS-c is not an approved drug and is offered strictly for laboratory research and educational purposes only; nothing here is medical advice or intended to guide human use.
Molecular data
Mechanism of action
In preclinical research, MOTS-c is associated with the following pathways and targets:
Research highlights
- Activates AMPK, the master metabolic regulator
- Improves insulin sensitivity and glucose uptake in skeletal muscle
- Mitochondria-to-nucleus retrograde signaling peptide
- Anti-aging effects observed in multiple preclinical models
Frequently asked questions
What is MOTS-c and what does it do?
MOTS-c is a 16-amino-acid peptide encoded by mitochondrial DNA. In research settings it is studied as a mitochondrial-derived signaling peptide that appears to influence cellular metabolism, largely through effects reported on the AMPK energy-sensing pathway. Its biological roles are still being characterized, and most evidence comes from laboratory and animal models rather than human studies.
How is MOTS-c thought to affect metabolism?
Preclinical studies suggest MOTS-c can activate AMPK signaling, which is associated in those models with increased glucose uptake in skeletal muscle and improved insulin sensitivity. It is also described as a 'retrograde' signal that may travel to the nucleus and influence metabolism-related gene expression under stress. These are proposed mechanisms observed experimentally, not confirmed clinical effects.
Why is MOTS-c studied in relation to exercise and aging?
Some research has reported that MOTS-c levels change with physical activity and that circulating levels may decline with age in certain measurements. This has made it a subject of interest in exercise physiology and aging biology. The relationships are still being investigated and should be viewed as active research questions rather than settled conclusions.
Is MOTS-c the same as a mitochondrial supplement like NAD+?
No. NAD+ is a coenzyme central to energy metabolism and sirtuin activity, while MOTS-c is a peptide encoded in mitochondrial DNA that acts as a signaling molecule. They are studied in overlapping areas — mitochondrial function and metabolic health — but are chemically and functionally distinct compounds.
Is MOTS-c approved for human use?
No. MOTS-c is not an approved drug and its use in humans has not been established through completed clinical trials. It is supplied for laboratory research and educational purposes only, and none of the research discussion here should be interpreted as medical guidance.
Source MOTS-c at Purgo Labs
≥99% purity, third-party COA verification, and same-day fulfillment.
Shop MOTS-c at Purgo Labs ↗Related compounds
For research and educational purposes only. MOTS-c is not approved for human use by any regulatory authority, and nothing on this page constitutes medical advice, diagnosis, or treatment. Research findings referenced here are predominantly preclinical.